ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 59 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,235,033 | -33.9% | 2,808,034 | 0.0% | 10.68% | -25.4% |
Q2 2023 | $29,119,313 | +28.2% | 2,808,034 | 0.0% | 14.32% | +21.5% |
Q1 2023 | $22,716,995 | -48.6% | 2,808,034 | 0.0% | 11.79% | -37.6% |
Q4 2022 | $44,226,536 | +0.1% | 2,808,034 | 0.0% | 18.89% | +32.9% |
Q3 2022 | $44,198,000 | +12.8% | 2,808,034 | 0.0% | 14.21% | +34.7% |
Q2 2022 | $39,200,000 | -21.6% | 2,808,034 | -3.1% | 10.56% | -24.5% |
Q1 2022 | $49,979,000 | +1.1% | 2,899,034 | -14.7% | 13.98% | +37.5% |
Q4 2021 | $49,422,000 | -19.2% | 3,399,034 | 0.0% | 10.17% | +12.9% |
Q3 2021 | $61,183,000 | +2.5% | 3,399,034 | 0.0% | 9.01% | +11.7% |
Q2 2021 | $59,687,000 | -30.3% | 3,399,034 | 0.0% | 8.07% | -21.4% |
Q1 2021 | $85,656,000 | +1291.6% | 3,399,034 | +257.3% | 10.26% | +1433.6% |
Q4 2020 | $6,155,000 | +1554.6% | 951,384 | +556.7% | 0.67% | +696.4% |
Q3 2020 | $372,000 | -93.3% | 144,874 | -80.6% | 0.08% | -96.7% |
Q4 2018 | $5,529,000 | -28.1% | 748,132 | +41.3% | 2.54% | +0.7% |
Q3 2018 | $7,689,000 | -27.3% | 529,551 | 0.0% | 2.52% | -30.1% |
Q2 2018 | $10,575,000 | +40.5% | 529,551 | +23.3% | 3.60% | +15.5% |
Q1 2018 | $7,526,000 | +21.1% | 429,551 | +70.5% | 3.12% | -28.4% |
Q4 2017 | $6,213,000 | – | 251,936 | – | 4.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 2,808,034 | $29,119,313 | 14.32% |
Foresite Capital Management V, LLC | 1,258,243 | $13,047,980 | 9.53% |
GREAT POINT PARTNERS LLC | 1,941,581 | $20,134,195 | 3.94% |
Bain Capital Life Sciences Investors, LLC | 3,400,000 | $35,258,000 | 3.63% |
Aisling Capital Management LP | 434,455 | $4,505,298 | 2.21% |
SILVERARC CAPITAL MANAGEMENT, LLC | 651,400 | $6,755,018 | 2.09% |
VR Adviser, LLC | 1,040,754 | $10,792,619 | 1.73% |
Ikarian Capital, LLC | 796,300 | $8,257,631 | 1.32% |
Samsara BioCapital, LLC | 696,171 | $7,219,293 | 1.27% |
BRAIDWELL LP | 2,901,194 | $30,085,382 | 0.98% |